Drug profile · INN
tiotropium
BRALTUS
tiotropium (BRALTUS) is a muscarinic acetylcholine receptor m3 antagonist. Associated with Lacuna Pharma Pty Ltd.
TGA: approved NMPA: clinical trials
Patents linked 0
Pipeline programs 12
News articles 0
Drug details — tiotropium
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 12
- Data quality
- 0.81
Quick answer
tiotropium (BRALTUS) is a muscarinic acetylcholine receptor m3 antagonist. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN tiotropium
Brand BRALTUS
Mechanism Muscarinic acetylcholine receptor M3 antagonist
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Muscarinic acetylcholine receptor M3 antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is tiotropium?
tiotropium (BRALTUS) is a muscarinic acetylcholine receptor m3 antagonist. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for tiotropium?
BRALTUS is a marketed brand name for tiotropium. Check FDA Drugs@FDA for the current US label holder and prescribing information.